Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Article
CAS
Google Scholar
Kumar N, Bhatnagar S, Velpandian T (2013) Randomized controlled trial in advance stage breast cancer patients for the effectiveness on stress marker and pain through sudarshan kriya and pranayam. Ind J Palliat Care 19:180–185
Article
Google Scholar
Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752
Article
CAS
Google Scholar
Shareef M, Ashraf MA, Sarfraz M (2016) Natural cures for breast cancer treatment. Saudi Pharm J 24(3):233–240
Article
Google Scholar
Cheang MC, Voduc D, Bajdik C (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Can Res 14:1368–1376
Article
CAS
Google Scholar
Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F (2019) Breast cancer. Nat Rev Dis Primers 5(1):66
Article
Google Scholar
Morgan CA, Hurley TD (2015) Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1. Chem Biol Interact 234:29–37
Article
CAS
Google Scholar
Vasiliou V, Nebert DW (2005) Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2(2):138
Article
CAS
Google Scholar
Vidovic D, Huynh TT, Konda P, Dean C, Cruickshank BM, Sultan M, Coyle KM, Gujar S, Marcato P (2020) ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells. Cell Death Differ 27(1):363–378
Article
CAS
Google Scholar
Shoeb M (2008) Anticancer agents from medicinal plants. Bangladesh J Pharmacol 1(2):35–41
Article
Google Scholar
Greenwell M, Rahman PK (2015) Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res 6:4103–4112
CAS
PubMed
PubMed Central
Google Scholar
Nyamai DW, Arika W, Ogola PE (2016) Medicinally important phytochemicals: an untapped research avenue. J Pharm Phytochem 1:4
Google Scholar
Jayameena P (2018) Rutin: a potential anticancer drug against human colon cancer (HCT116) cells. Int J Biol Pharm Allied Sci 7(9):1731–1745
CAS
Google Scholar
Iriti M, Kubina R, Cochis A, Sorrentino R, Varoni EM, Kabała-Dzik A, Azzimonti B, Dziedzic A, Rimondini L, Wojtyczka RD (2017) Rutin, a quercetin glycoside, restores chemosensitivity in human breast cancer cells: rutin restores chemosensitivity in breast cancer cells. Phytother Res 31(10):1529–1538
Article
CAS
Google Scholar
Moitessier N, Englebienne P, Lee D (2009) Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go: docking/scoring methods-a review. Br J Pharm 153(S1):7–26
Article
Google Scholar
Kulkarni SS (2012) A comparative study of cDNA microarray analysis of familial and sporadic breast cancer in India. J Med Genet Genomics 4(1):6–12
CAS
Google Scholar
Martina MK, Mirela S, Nela M (2011) Electroanalytical characterization of a copper(II)-rutin complex. Int J Electrochem Sci 6:1075–1084
Google Scholar
Shah T, Joshi K, Mishra S, Otiv S, Kumbar V (2016) Molecular and cellular effects of vitamin B12 forms on human trophoblast cells in presence of excessive folate. Biomed. Pharmacother 84:526–534
Article
CAS
Google Scholar
Kalirajan R, Rafick MHM, Sankar S, Jubie S (2012) Docking studies, synthesis, characterization and evaluation of their antioxidant and cytotoxic activities of some novel isoxazole-substituted 9-anilinoacridine derivatives. Sci World J 2012:1–6
Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T (2010) Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women. Breast Cancer Res Treat 123(3):885–893
Article
CAS
Google Scholar
Qiu Y, Pu T, Li L (2014) The expression of aldehyde dehydrogenase family in breast cancer. J Breast Cancer 17(1):54
Article
Google Scholar
Marcato P, Dean CA, Liu RZ, Coyle KM, Bydoun M, Wallace M, Clements D, Turner C, Mathenge EG, Gujar SA, Giacomantonio CA, Mackey JR, Godbout R, Lee PWK (2015) Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling. Mol Oncol 9(1):17–31
Article
CAS
Google Scholar
Ochwang’i DO, Kimwele CN, Oduma JA, Gathumbi PK, Mbaria JM, Kiama SG (2014) Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya. J Ethnopharmacol 151(3):1040–1055
Article
Google Scholar
Selvakumar P, Badgeley A, Murphy P (2020) Flavonoids and other polyphenols act as epigenetic modifiers in breast cancer. Nutrients 12:761
Article
CAS
Google Scholar
Deepika MS, Thangam R, Sheena TS, Sasirekha R, Sivasubramanian S, Babu MD, Jeganathan K, Thirumurugan R (2019) A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis. Biomed Pharmacother 109:1181–1195
Article
CAS
Google Scholar
Ugai T, Milne RL, Ito H, Aronson KJ, Bolla MK, Chan T, Chan CW, Choi JY, Conroy DM, Dennis J, Dunning AM, Easton DF, Gaborieau V, Gonzalez-Neira A, Hartman M, Healey CS, Iwasaki M, John EM, Kang D, Kim SW, Kwong A, Lophatananon A, Michailidou K, Taib NAM, Muir K, Park SK, Pharoah PDP, Sangrajrang S, Shen CY, Shu XO, Spinelli JJ, Teo SH, Tessier DC, Tseng CC, Tsugane S, Vincent D, Wang Q, Wu AH, Wu PE, Zheng W, Matsuo K (2019) The functional ALDH2 polymorphism is associated with breast cancer risk: a pooled analysis from the breast cancer association consortium. Mol Genet Genomic Med 7(6):707
Article
Google Scholar